Next Article in Journal
Congenital Sepsis with Candida albicans—A Rare Event in the Neonatal Period: Report of Two Cases and Literature Review
Previous Article in Journal
Effects of 5-Aminolevulinic Acid Supplementation on Gas Production, Fermentation Characteristics, and Bacterial Community Profiles In Vitro
Previous Article in Special Issue
Navigating Novel Viral Challenges: Understanding, Tracking, and Mitigating Emerging Threats
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Survey of Hepatitis B Virus and Hepatitis E Virus at the Human–Wildlife Interface in the Peruvian Amazon

by
María Fernanda Menajovsky
1,
Johan Espunyes
2,3,
Gabriela Ulloa
4,
Stephanie Montero
5,6,
Andres G. Lescano
5,7,
Meddly L. Santolalla
5,
Oscar Cabezón
2,8 and
Pedro Mayor
1,9,10,*
1
Departament de Sanitat i Anatomia Animals, Facultat de Veterinària, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain
2
Unitat Mixta d’Investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autonoma de Barcelona (UAB), Catalonia, 08193 Bellaterra, Spain
3
Institute of Agrifood Research and Technology (IRTA), Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autonoma de Barcelona (UAB), Catalonia, 08193 Cerdanyola del Valles, Spain
4
Programa de Pós-Graduação em Saúde e Produção Animal na Amazônia, Universidade Federal Rural da Amazônia (UFRA), Belém 66077-830, Brazil
5
Emerge, Emerging Diseases and Climate Change Research Unit, School of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima 15015, Peru
6
School of Medicine, Universidad Peruana de Ciencias Aplicadas (UPC), Lima 15067, Peru
7
Clima, Latin American Center of Excellence for Climate Change and Health, Universidad Peruana Cayetano Heredia, Lima 15024, Peru
8
Wildlife Conservation Medicine Research Group (WildCoM), Departament de Medicina i Cirurgia Animals, Universitat Autonoma de Barcelona, 08193 Bellaterra, Spain
9
ComFauna, Comunidad de Manejo de Fauna Silvestre en la Amazonía y en Latinoamérica, Iquitos 16006, Peru
10
Museo de Culturas Indígenas Amazónicas, Iquitos 16006, Peru
*
Author to whom correspondence should be addressed.
Microorganisms 2024, 12(9), 1868; https://doi.org/10.3390/microorganisms12091868
Submission received: 4 August 2024 / Revised: 4 September 2024 / Accepted: 6 September 2024 / Published: 10 September 2024

Abstract

:
Hepatitis B virus (HBV) and Hepatitis E virus (HEV) are zoonotic pathogens posing significant health concerns in rural Amazonia, a region marked by high endemicity, poverty, and limited healthcare access. However, the epidemiology of HBV and HEV in this ecosystem remains underexplored. This study examines the circulation of HBV and HEV at the human–wildlife interface and identifies risk factors within an isolated Amazonian indigenous community reliant on hunting for subsistence. Antibodies against HBV core antigens (HBcAbs) were found in three wildlife species: Cuniculus paca (0.8%), Tayassu pecari (1.6%), and Mazama americana (4.1%), marking the first record of HBV antibodies in free-ranging wildlife in the Amazon. However, further research is necessary to identify circulating strains and their relation to human HBV. HBcAbs were also detected in 9.1% of human samples, confirming exposure to HBV in the region. HEV IgG antibodies were present in 17.1% of humans and were associated with higher age. All wildlife and domestic animal samples tested negative for HEV, but transmission through consumption of wild animals and contaminated water needs further investigation. The identified risk factors highlight the urgent need for measures to promote safer food handling, improved sanitation, hygiene, and practices related to contact with wild animals.

1. Introduction

Hepatitis B virus (HBV) and Hepatitis E virus (HEV) are critical health concern worldwide, particularly in low- and medium-income countries (LMIC) [1,2,3]. In particular, in rural Amazonia, diverse areas of high endemicity for HBV and HEV have been identified, exacerbated by high levels of poverty and limited access to healthcare [4,5,6].
HBV, a DNA virus from the Family Hepadnaviridae, affects around one-third of the world population [7] and is responsible for approximately one million deaths annually due to cirrhosis, liver failure, hepatocellular carcinoma [8], and immune dysfunction linked to the intensification of other viral infections [9]. For decades, HBV has been hyperendemic in Amazonian rural populations, with a prevalence of over 50%, resulting in chronic active hepatitis and liver cirrhosis [4,10,11,12,13]. Transmission in these communities primarily occurs through direct contact with infected bodily fluids—including sexual intercourse and perinatal transmission—getting tattooed, and contact with non-indigenous populations [4,13,14]. This virus often exhibits genetic variants that are linked with specific hosts, but some studies indicate the presence of HBV and HBV-like in different wild mammals, suggesting the virus’s ability to infect and share hosts within their natural habitats [15,16,17,18]. While HBV transmission from wildlife reservoirs—often linked to bat bites, frequent in communities that regularly interact with wildlife—has been proposed and transmission between species of primates has been suggested [15,19], the transmission in rural communities with frequent contact with wildlife remains understudied [4].
HEV, an RNA virus from the Family Hepeviridae, is the main cause of acute viral hepatitis in humans worldwide and is associated with large outbreaks and epidemics in LMIC [20]. HEV is an emerging food-borne pathogen, generally transmitted through the handling and consumption of raw and undercooked infected meat and meat-derived products [21]. Acute outbreaks have also been reported in rural Amazonian communities due to lack of access to potable water and inadequate sanitation [3]. In South America, rural communities present seroprevalences ranging from 2.1% to 17% [22,23]. However, essential epidemiological aspects related to human zoonotic transmission still remain underexplored [6,23]. Domestic pigs and wild boars are considered the main reservoirs of HEV worldwide; however, the virus has also been identified in a wide range of wildlife species [24,25]. In Amazon rural communities, where animal farming and consumption of processed pork products are uncommon, there is a potential risk of HEV exposure from consuming infected wild meat or water and from direct contact with wild animals during hunting activities [6].
Despite the importance of HBV and HEV in the health of Amazonian rural communities, the functional role of wild mammals in HBV and HEV transmission through complex wildlife–human interactions facilitated by hunting and wild meat manipulation remains underexplored [26,27,28]. The present study aimed at evaluating HBV and HEV circulation in the human–wildlife interface and identifying risk factors and behaviors using a sociological analysis in an indigenous community that relies on subsistence hunting in a well-conserved and isolated area of the Peruvian Amazon.

2. Materials and Methods

2.1. Study Area

This study was conducted in the Yagua indigenous community of Nueva Esperanza, located in the Yavarí-Mirín River basin (04°19′53″ S; 71°57′33″ W; UT5: 00), a geographically isolated and well-preserved forest along the border between Brazil and Peru in the Peruvian Amazon (Figure 1) [29]. This community of 370 people relies on a subsistence economy based on small-scale agriculture, hunting, and fishing [30,31]. The absence of feral pigs and livestock eliminates the possibility of disease transmission from these domestic sources [31]. Hepatitis-related mortality has been observed in other rural communities in the Yavarí River basin for over fifteen years, and since 2001, they have been grappling with a severe HBV outbreak [32]; 22 individuals died between 2001 and 2004, some with confirmed HBV and others with symptoms of hepatitis [33]. However, the lack of laboratory confirmation and serological data hinders authorities from addressing this situation [32].
Immunity against HBV in indigenous communities bordering Brazil and Peru in the Yavarí River basin is notably low due to lack of vaccination programs or significant delays between doses [32]. In the Peruvian Amazon, studies show that vaccination records are not well registered and serological tests do not align with reported vaccinations [34]. In the studied community, the indigenous population does not report any specific vaccination program against HBV, suggesting that the local population has not been appropriately vaccinated.

2.2. Blood Sample Collection

The blood sampling of wildlife took advantage of the discarded material from subsistence hunting, allowing for an extensive collection of 431 wild animals consumed by the local inhabitants between 2008 and 2020, including 125 peccaries (62 Tayassu pecari and 63 Pecari tajacu), 122 pacas (Cuniculus paca), 83 brocket deers (74 Mazama americana and nine Mazama nemorivaga), 66 primates (25 Lagothrix poeppigii, 15 Sapajus macrocephalus, 6 Ateles chamek, 6 Pithecia monachus, 5 Cacajao calvus, 5 Cebus albifrons, 2 Saimiri macrodon, 1 Alouatta seniculus, and 1 Plecturocebus cupreus), and 35 tapirs (Tapirus terrestris). In September 2019 and February 2020, a total of 43 peri-domestic rodents (38 rats and 5 mice) were also sampled. Blood samples were collected on either Whatman filter paper n. 3 or FTA® cards (Scheilcher & Schuell, Dassel, Germany), preserved from 15 to 100 days in the community and later transported and stored at −70 °C, as previously reported [35,36].
Whole blood samples were also collected from 88 local residents, including 35 men and 53 women (39.8% vs. 60.2%, respectively), aged between 5 and 79 years, with a median age of 25 (10.0–34.0). Serum was extracted from the samples, stored in liquid nitrogen for transport, and then stored at −70 °C until laboratory analysis.

2.3. Laboratorial Procedures

Blood-soaked filter papers containing the animal samples were processed by cutting a 132 mm2 piece, which was eluted in 400 µL of sterile phosphate-buffered saline (PBS) before vortexing for 20 s. The samples were stored at 4 °C for 24 h, then vortexed and frozen at −20 °C until analysis. The elutions from wild and peri-domestic animals and the human serum samples were tested for antibodies against HBV core antigens (HBcAbs) using the commercial ELISA kit “Human anti-hepatitis B virus core antibody” (Cusabio, Wuhan, China) [37]. HBcAbs are used to detect past or current HBV infections but does not indicate immunity from vaccination [38]. IgG antibodies against HEV were screened using the “ID Screen® Hepatitis E Indirect Multi-species” kit (IDvet, Montpellier, France) for samples from wild and peri-domestic animals. For human blood samples, analysis for HEV antibodies was performed using the “Human hepatitis E virus antibody (IgG)” kit from Cusabio (Wuhan, China). Both commercial ELISA kits against HBcAb and HEVAb had intra- and inter-assay precision of CV% < 15%.
A recent study using the same samples on Whatman filter paper n. 3 and FTA® cards revealed that only the DNA quantity and quality were adequate for molecular tests, whereas RNA was likely of limited use for viral pathogen research [39]. For this reason, only HBV DNA was extracted from the samples using the IndiMag Pathogen kit (Indical Bioscience, Leipzig, Germany), and the quality and quantity of DNA were determined using the Qubit dsDNA BR Assay Kit (Fisher Scientific, Waltham, MA, USA). A qPCR was conducted to detect HBV DNA using Promega PCR Master Mix, following the manufacturer’s instructions (Promega Corporation, Madison, WI, USA). The PCR analyzed the pre-S2/S region using the following primer pair and fluorescent probe purchased from Integrated DNA Technologies (IDT): forward primer (50-GAATCCTCACAATACCGCAGAGT-30), reverse primer (50-GCCAAGACACACGGGTGAT-30), and probe (50-FAM-AAGTCCACCACGAGTCTAG-NFQ/MGB-30) [25]. A plasmid carrying a human HBV 1.3 mergenome was used as a positive control. Given budget limitations, only 68 samples were analyzed, including all seropositive animals and humans.

2.4. Interviews for Risk Assessment

In 2020, we used semi-structured surveys to collect data on habits and activities in the community to identify potential risk factors related to HBV and HEV infections. Interviews were conducted for 84 heads of families (47 (55.9%) women and 37 (44.1%) men, aged 18 to 77) from 42 different households (76.4% of total households). The questions were focused on activities usually related to the transmission of HBV, HEV, and other common bloodborne or foodborne pathogens, such as outdoor activities, especially hunting, but also contact with animals, the presence of domestic animals in households, and meat preparation and processing, as highlighted in previous studies [4,6,10,13,14,15,40,41]. The semi-structured surveys were divided into sections addressed to people based on their roles and activities within the community (See “Results section” for the detailed questions of the survey). Consequently, the number of respondents varied across different survey questions. By analyzing this information, we aimed to highlight practices that may expose individuals to HBV and HEV, allowing us to better understand the virus transmission and design appropriate prevention strategies [35].

2.5. Statistical Analysis

A Generalized Linear Model (GLM) was employed to analyze the correlation between HBV and HEV antibody presence in wildlife and explanatory factors including species, habitat, and diet. The serological status (negative or positive) was utilized as the response variable, while “Habitat” (terrestrial/arboreal) and “Diet” (herbivorous/frugivorous/omnivorous/carnivorous) were considered as fixed explanatory variables.
Two GLMs were employed to examine the effect of age (in years) and sex (and their interaction) in relation to the serological results for HBV and HEV in humans. The response variable was the serological result, categorized as positive or negative. Model selection was based on the Akaike Information Criterion (AIC) [42].
GLM was also used to analyze the data collected in surveys on habits and activities in the community, with the aim of identifying potential risk factors related to HBV and HEV seropositivity. The serological status (negative or positive) was utilized as the response variable.
All data analyses were performed using R 4.2.2 [43], and we considered a Type I error probability of 0.05 for hypothesis testing.

3. Results

3.1. Serological Analysis

HBcAbs were only detected in three wildlife species: Cuniculus paca (0.8%; 1/122, 95% CI 0.1–0.5%), Tayassu pecari (1.6%; 1/62, 95% CI 0.3–8.6%), and Mazama americana (4.1%, 3/74; 95% CI 1.4–11.3%). The rest of the samples from wild animals were negative (Table 1). The serology of peri-domestic rodents was also negative, including rats (0/38; 0.0% CI 0.0–9.2%) and mice (0/5; 0.0% CI 0.0–43.5%). No significant association was observed between the HBV seroprevalence and biological or ecological factors (p > 0.05).
In addition, HBcAbs were detected in 9.1% (8/88; 95% CI 4.7–16.9%) of the human samples. The models with the lowest AICs among all models were considered, specifically those with AIC differences of less than two, which included the models’ age (Akaike weight by age = 0.43), sex (Akaike weight by sex = 0.22), and ‘Sex + Age’ (Akaike weight by Sex + Age = 0.24) (Table 2); however, no significant association was observed between the HBV seroprevalence and age or sex (p > 0.05).
Antibodies against HEV were not found in wildlife (0.0%, 0/431, 95% CI 0.0–0.9%) or peri-domestic animals (0.0%, 0/43, 95% CI 0.0–8.2%), but were detected in 17.1% (15/88, 95% CI 10.6–26.4%) of humans. The models with the lowest AICs among all models were considered, specifically those with AIC differences of less than two, which included the models’ age (Akaike weight by age = 0.50) and Sex + Age (Akaike weight by Sex + Age = 0.33) (Table 3). The frequency of HEV seropositivity in humans increased with age (Estimate = 0.045, Std. Error = 0.018, z value= 2.264, p = 0.0104), but the influence of the sex of individuals was not statistically significant (p > 0.05).

3.2. Molecular Analysis

The sixty-eight samples analyzed by conventional PCR to detect HBV DNA included sixty seronegative samples (twenty Cuniculus paca, twenty Mazama americana, ten Pecari tajacu, and ten Tayassu pecari) and eight seropositive human samples. All samples resulted negative.

3.3. Risk Factors

The semi-structured surveys revealed that all inhabitants consume wild meat, which is cooked with water from unsafe sources (rivers, rain, streams) as they do not have access to potable water (Table 3). As drinking water, the local population mainly consumes rainwater and previously sedimented river water, but without purification treatment. A significant portion of the community consume meat with macroscopic lesions, meat prepared at low temperatures, offal, and even animals found dead in the forest. Additionally, domestic (cats, dogs, and chicken) and wild animals frequently come into contact with residents, and bat and mouse bites are common. In terms of safety practices, hunters admitted to not using protective measures when handling hunted animals, with some reporting injuries. Furthermore, a notable portion of the population does not use condoms for reproductive control and/or to prevent the spread of sexually transmitted infections. Table 4 summarizes other activities associated with HBV and HEV exposure.

4. Discussion

The present study improves the knowledge of the occurrence of HBV and HEV in humans and coexisting wildlife in the rural Peruvian Amazon. Antibodies against HBV were detected in three wild mammal species and both HEV and HBV antibodies were detected in humans. To our knowledge, this is the first record of antibodies against HBV in free-ranging wildlife in the Amazon region.
In the non-Amazon areas of Brazil, previous research has shown the occurrence of a virus phylogenetically close to human HBV sequences in domestic swine and wild boars (Sus scrofa), horses (Equus ferus caballus), domestic dogs (Canis lupus familiaris), jaguars (Panthera onca), maned wolves (Chrysocyon brachyurus), and crab-eating raccoons (Procyon cancrivorus) [18,26]. The presence of HBV antibodies across three distinct wildlife species in our study underscores the complexity of transmission, supporting the hypothesis that HBV or HBV-like viruses can infect different hosts in their natural habitats [15,26]. However, despite the high precision of the kits used, we cannot rule out the possibility of false negatives. On the other hand, further studies are required to determine which strains and genotypes are circulating in the Amazon and if they are closely related to human HBV, as previously observed in domestic pigs [18], and whether this virus is exchanged between animals and humans.
In the Amazon, human HBV prevalence ranges from 0 to 30% [44,45,46] and most studies found no clear gender-related nor age-related risk [18,47,48,49], which is consistent with our results. Our results confirm human exposure to HBV in the Yavarí-Marín River basin, stressing the need for the implementation of an appropriate vaccination program, highlighting the importance of extensive research across the Amazon to determine the prevalence and risk of HBV.
On the other hand, HEV circulation has been widely documented in domestic and wild fauna in South America [50,51,52]. In our study, all samples from wild and domestic animals were negative for antibodies against HEV. On the contrary, we observed a high seroprevalence of HEV in humans associated with age, as reported by previous studies [22,53], suggesting continuous and cumulative exposure to the virus over time [54]. However, RNA analysis, which could have provided more meaningful insights, was not performed due to the highly degraded RNA in our filter paper samples, as reported in a previous study using these same samples and demonstrating the greater degradation of RNA compared to DNA [39]. Our findings suggest that wild meat consumption is not a major factor in HEV transmission; however, this transmission through contact with or consumption of wild animals needs to be further explored, given the absence of interaction with pigs and consumption of pork products in the community. Our results also reinforce the idea that other environmental factors are causing repeated infection processes in humans. Some studies have demonstrated that HEV may be transmitted via the fecal–oral route from contaminated water and large waterborne outbreaks frequently occur, especially in developing countries [55,56,57]. However, the lack of reports on water-borne HEV outbreaks in the Amazon [50] evidences that this potential transmission route is not well studied. Further studies are needed to improve knowledge about the source of contamination, its occurrence, and its survival in water.
Due to a low correspondence between serologically analyzed individuals and survey participants, the association between risk factors and serology results could not be analyzed. Despite this limitation, we have identified several common risk factors in Nueva Esperanza that may constitute a risk of HBV and HEV transmission according to the scientific literature [4,6,10,13,14,15,40,41]. This highlights the need to implement measures to promote safer food handling while also improving sanitation, hygiene, and practices related to close contact with wild animals and the purification of drinking waters. To address the hepatitis burden in the Yavarí River basin, it is critical to target specific risk factors. These results also underscore the need to explore and study cultural practices and animal reservoirs in the Amazon region, which may influence infectious disease pathways [58,59].
Traditionally, wildlife health data from isolated tropical environments has been restricted due to limited sampling capacity in such conditions; however, our long-term fieldwork in the study area, in collaboration with local people, allowed the collection of a large number of blood samples from wildlife. Previous studies demonstrated that serological tests are feasible with samples preserved on filter paper and that DNA could be preserved under these conditions [29,35,39], and we encourage researchers with similar samples to conduct serological and molecular DNA analyses to improve the understanding of virus circulation at the wildlife–human interface in remote Amazon environments.

5. Conclusions

Our study provides evidence of past occurrences of HEV and HBV in humans in a remote Amazonian indigenous community. However, we were unable to confirm current infections due to a lack of molecular detection of both viruses. Additionally, we detected HBV antibodies in wild animals but could not clearly confirm the role of wildlife in the dissemination or harboring of these viruses, particularly in the foodborne transmission of HEV. To reach firmer conclusions, large-scale investigations with advanced molecular techniques are required. Nonetheless, the community’s traditional practices and behaviors, such as hunting and the eating wild meat, may significantly increase the risk of these diseases. Addressing these health risks through targeted interventions and public health initiatives is crucial to safeguarding the well-being of vulnerable rural communities that share such practices worldwide [40,41,60,61].

Author Contributions

Conceptualization, M.F.M., J.E., O.C. and P.M.; methodology, M.F.M., J.E., G.U., M.L.S., O.C. and P.M.; software, M.F.M. and J.E.; formal analysis, M.F.M., J.E., G.U. and O.C.; investigation, M.F.M., J.E., G.U., S.M., M.L.S., O.C. and P.M.; resources, G.U., A.G.L., M.L.S. and P.M.; data curation, M.F.M., G.U. and P.M.; writing—original draft preparation, M.F.M., J.E., O.C. and P.M.; writing—review and editing, M.F.M., J.E., G.U., O.C. and P.M.; supervision, J.E., O.C. and P.M.; project administration, J.E., G.U., M.L.S., O.C. and P.M.; funding acquisition, G.U., A.G.L., M.L.S. and P.M. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by ERANet-LAC (ERANet17/HLH-0271), research projects (nº 136-2018-FONDECYT; AC18/00054 Instituto de Salud Carlos; 400800/2019-5 CNPq), Fundació Autònoma Solidària (n° FS-XXXVI-FS1) y Global GreenGrants Funds (n° 2020-4226), and the training grant D43 TW007393 awarded by the Fogarty International Center of the US National Institutes of Health, who also supported MLS and AGL. M.F.M. acknowledges a doctoral scholarship from the Catalan Agency for Management of University and Research Grants [scholarship FI-SDUR EMC/3345/2020] and received the funding from the Royal Society of Tropical Medicine and Hygiene (RSTMH) as part of a small research grant initiative “https://www.rstmh.org/grants/grant-awardees-2021 (accessed on 7 September 2024)”. GU received two grants from the CNPq PPGSPAA program in GD modality (140312/2020-0) and SWE modality (201546/2020-5).

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of the Universidad Peruana Cayetano Heredia (Peru) (102142; 8 May 2019), the Ethics Committee of the Universitat Autònoma de Barcelona (Spain) (CEEAH 4829; 13 December 2019), and the Ethics Committee of the Hospital Clinic of Barcelona (HCB/2019/1107; 19 December 2019). This study was also presented to the local authorities of Nueva Esperanza as well as regional and local authorities (n◦ 267-2019-GRL-DRSL/30.09.01). Prior to blood collection, members of the community were informed and informed consent forms were voluntarily signed, which were also approved by the Ethics Committee. The research protocols for the sampling of wildlife were approved by the Peruvian Forest and Wildlife Service (n◦ 258-2019-MINAGRI-SERFOR-DGGSPFFS; 27 May 2019) and the Institutional Animal Use Ethics Committee of the Universidad Peruana Cayetano Heredia (ref. 102142; 14 May 2019). Dried blood samples on filter paper from wildlife were exported with the approval of the Peruvian Forestry and Wildlife Service (n◦ 003258/SP-Peru, n◦ 003260/SP-Peru, n◦ 003568-SERFOR-Peru, n◦ 003579-SERFOR-Peru, BB-00017 20I-Spain and BB-00018 20I-Spain).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available because it includes confidential information from people who participated in the study, even if they are anonymous.

Acknowledgments

We sincerely thank all the people from Nueva Esperanza who actively participated in data collection, which shows that communal participation is an important step in the development of wildlife management. We also extend our thanks to R. Bodmer, P. E. Puertas, and P. Pérez for their kind assistance during the fieldwork. We are very grateful to the members of the Emerge group of the Universidad Peruana Cayetano Heredia (UPCH) for their research work in field epidemiology. We also want to thank the Regional Directorate of Health and Management of Indigenous Affairs of the Regional Government of Loreto, the Iquitos Air Wing No. 5 of the Peruvian Air Force, the Municipality and the Health Medical Center of Islandia, the Comité Permanente de Atención Integral en Salud (CPAIS) of the Scientific Society of San Fernando (Universidad Nacional Mayor de San Marcos), Campamento Universitario Multidisciplinario de Investigación y Servicio (CUMIS), the team of the Research Unit in Emerging Diseases and Climate Change of the Peruvian University Cayetano Heredia, Katherina Alicia Viscaychipi, Milagritos Fernández Larrauri, and the team of physicians Janet Cordori Carpio, Jackeline Magaly Tinoco Figueroa, Cristian Hipólito Andonaire Munaico, Augusto Gavino Escalante Candía, Saúl Javier Santiváñez Salazar, Sabina Mendivil Tuchiand José Antonio Salinas Morales.

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.

References

  1. Purcell, R.H.; Emerson, S.U. Hepatitis E: An emerging awareness of an old disease. J. Hepatol. 2008, 48, 494–503. [Google Scholar] [CrossRef] [PubMed]
  2. Grimm, D.; Thimme, R.; Blum, H.E. HBV life cycle and novel drug targets. Hepatol. Int. 2011, 5, 644–653. [Google Scholar] [CrossRef] [PubMed]
  3. WHO. Global Hepatitis Report 2017; World Health Organization: Geneva, Switzerland, 2017; Available online: https://iris.who.int/bitstream/handle/10665/255016/9789?sequence=1 (accessed on 20 April 2024).
  4. Costa, C.A.D.; Kimura, L.O. Molecular epidemiology of hepatitis B virus among the indigenous population of the Curuçá and Itaquaí Rivers, Javari Valley, State of Amazonas. Brazil. Rev. Soc. Bras. Med. Trop. 2012, 45, 457–462. [Google Scholar] [CrossRef] [PubMed]
  5. Cabezas, C.; Trujillo, O.; Gonzales-Vivanco, Á.; Benites Villafane, C.M.; Balbuena, J.; Borda-Olivas, A.O.; Suarez-Jara, M.A.; Peceros, F.M.; Ramírez-Soto, M.C. Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study. PLoS ONE 2020, 15, e0234273. [Google Scholar] [CrossRef]
  6. Vasconcelos, M.P.A.; de Oliveira, J.M.; Sánchez-Arcila, J.C.; Faria, S.C.; Rodrigues, M.M.; Perce-da-Silva, D.; Rezende-Neto, J.; Pinto, M.A.; Maia-Herzog, M.; Banic, D.M.; et al. Seroprevalence of the Hepatitis E Virus in Indigenous and Non-Indigenous Communities from the Brazilian Amazon Basin. Microorganisms 2024, 12, 365. [Google Scholar] [CrossRef]
  7. Carey, W.D. The prevalence and natural history of hepatitis B in the 21st century. Cleve Clin. J. Med. 2009, 76 (Suppl. S3), S2–S5. [Google Scholar] [CrossRef] [PubMed]
  8. Dienstag, J.L. Hepatitis B virus infection. N. Engl. J. Med. 2008, 359, 1486–1500. [Google Scholar] [CrossRef]
  9. Zhao, Z.Y.; Tang, H.C.; Li, F. Measles-associated severe pneumonia in a patient with HBeAg-negative chronic hepatitis B: A case report. Zoonoses 2022, 2, 3. [Google Scholar] [CrossRef]
  10. Cabezas, C.; Braga, W. Hepatitis B virus and delta infection: Special considerations in the indigenous and isolated riverside populations in the Amazon Region. Clin. Liver Dis. 2020, 16, 117–122. [Google Scholar] [CrossRef]
  11. Braga, W.S.M.; Brasil, L.M.; de Souza, R.A.B.; da Costa Castilho, M.; da Fonseca, J.C. The occurrence of hepatitis B and delta virus infection within seven Amerindian ethnic groups in the Brazilian western Amazon. Rev. Soc. Bras. Med. Trop. 2001, 34, 349–355. [Google Scholar]
  12. Braga, W.S.M.; Castilho, M.D.C.; Borges, F.G.; Martinho, A.C.D.S.; Rodrigues, I.S.; Azevedo, E.P.D.; Scazufca, M.; Menezes, P.R. Prevalence of hepatitis B virus infection and carriage after nineteen years of vaccination program in the Western Brazilian Amazon. Rev. Soc. Bras. Med. Trop. 2012, 45, 13–17. [Google Scholar] [CrossRef] [PubMed]
  13. Viana, S.; Paraná, R.; Moreira, R.; Compri, A.P.; Macedo, V. High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon. Am. J. Trop. Med. Hyg. 2005, 73, 808–814. [Google Scholar] [CrossRef]
  14. Ormaeche, M.; Whittembury, A.; Pun, M.; Suárez-Ognio, L. Hepatitis B virus, syphilis, and HIV seroprevalence in pregnant women and their male partners from six indigenous populations of the Peruvian Amazon Basin, 2007–2008. Int. J. Infect. Dis. 2012, 16, e724–e730. [Google Scholar] [CrossRef] [PubMed]
  15. Bonvicino, C.R.; Moreira, M.A.; Soares, M.A. Hepatitis B virus lineages in mammalian hosts: Potential for bidirectional cross-species transmission. World J. Gastroenterol. 2014, 20, 7665. [Google Scholar] [CrossRef]
  16. Vartanian, J.P.; Pineau, P.; Henry, M.; Hamilton, W.D.; Muller, M.N.; Wrangham, R.W.; Wain-Hobson, S. Identification of a hepatitis B virus genome in wild chimpanzees (Pan troglodytes schweinfurthi) from East Africa indicates a wide geographical dispersion among equatorial African primates. J. Virol. 2002, 76, 11155–11158. [Google Scholar] [CrossRef]
  17. Li, W.; She, R.; Liu, L.; You, H.; Yin, J. Prevalence of a virus similar to human hepatitis B virus in swine. Virol. J. 2010, 7, 60. [Google Scholar] [CrossRef] [PubMed]
  18. Vieira, Y.R.; Silva, M.F.; Santos, D.R.; Vieira, A.A.; Ciacci-Zanella, J.R.; Barquero, G.; do Lago, B.V.; Gomes, S.A.; Pinto, M.A.; De Paula, V.S. Serological and molecular evidence of hepadnavirus infection in swine. Ann. Agric. Environ. Med. 2015, 22, 11–16. [Google Scholar] [CrossRef]
  19. Cabezas, C.; Suárez, M.; Romero, G.; Carrillo, C.; García, M.P.; Reátegui, J.; Vallenas, F.; Torres, L. Hiperendemicidad de hepatitis viral B y delta en pueblos indígenas de la Amazonía peruana. Rev. Peru. Med. Exp. Salud Publica 2006, 23, 114–122. [Google Scholar]
  20. Meng, X.J. Hepatitis E virus: Animal reservoirs and zoonotic risk. Vet. Microbiol. 2009, 140, 256–265. [Google Scholar] [CrossRef]
  21. Harrison, L.C.; DiCaprio, E. Hepatitis E virus: An emerging foodborne pathogen. Front. Sustain. Food Syst. 2018, 2, 14. [Google Scholar] [CrossRef]
  22. Fernández, N.V.; Kessel, B.; Rodiah, I.; Ott, J.J.; Lange, B.; Krause, G. Seroprevalence of hepatitis E virus infection in the Americas: Estimates from a systematic review and meta-analysis. PLoS ONE 2022, 17, e0269253. [Google Scholar] [CrossRef] [PubMed]
  23. Pisano, M.B.; Martinez-Wassaf, M.G.; Mirazo, S.; Fantilli, A.; Arbiza, J.; Debes, J.D.; Ré, V.E. Hepatitis E virus in South America: The current scenario. Liver Int. 2018, 38, 1536–1546. [Google Scholar] [CrossRef]
  24. Moraes, D.F.D.S.D.; Mesquita, J.R.; Dutra, V.; Nascimento, M.S.J. Systematic review of hepatitis e virus in Brazil: A one-health approach of the human-animal-environment triad. Animals 2021, 11, 2290. [Google Scholar] [CrossRef]
  25. Ahmed, R.; Nasheri, N. Animal reservoirs for hepatitis E virus within the Paslahepevirus genus. Vet. Microbiol. 2022, 278, 109618. [Google Scholar] [CrossRef]
  26. Vieira, Y.R.; Portilho, M.M.; Oliveira, F.F.; Guterres, A.; Dos Santos, D.R.L.; Villar, L.M.; Mirazo, S.; Arbiza, J.; Dimache, L.A.; Almeida, F.Q.; et al. Evaluation of HBV-like circulation in wild and farm animals from brazil and Uruguay. Int. J. Environ. Res. Public Health 2019, 16, 2679. [Google Scholar] [CrossRef] [PubMed]
  27. Mirazo, S.; Gardinali, N.R.; Verger, L.; Ottonelli, F.; Ramos, N.; Castro, G.; Pinto, M.A.; Ré, V.; Pisano, B.; Lozano, A.; et al. Serological and virological survey of hepatitis E virus (HEV) in animal reservoirs from Uruguay reveals elevated prevalences and a very close phylogenetic relationship between swine and human strains. Vet. Microbiol. 2018, 213, 21–27. [Google Scholar] [CrossRef]
  28. Cunha, L.; Luchs, A.; Azevedo, L.S.; Silva, V.C.; Lemos, M.F.; Costa, A.C.; Compri, A.P.; França, Y.; Viana, E.; Malta, F.; et al. Detection of Hepatitis E Virus Genotype 3 in Feces of Capybaras (Hydrochoeris hydrochaeris) in Brazil. Viruses 2023, 15, 335. [Google Scholar] [CrossRef] [PubMed]
  29. Pitman, R.L.; Beck, H.; Velazco, P.M. Mamíferos terrestres y arbóreos de la selva baja de la Amazonía Peruana; entre los ríos Manu y Alto Purús. In Alto Purus: Biodiversidad, Conservación y Manejo; Center for Tropical Conservation, Nicholas School of the Environment, Duke University: Durham, NC, USA, 2003; pp. 109–122. [Google Scholar]
  30. Mayor, P.; Pérez-Peña, P.; Bowler, M.; Puertas, P.E.; Kirkland, M.; Bodmer, R. Effects of selective logging on large mammal populations in a remote indigenous territory in the northern Peruvian Amazon. Ecol. Soc. 2015, 20, 9. [Google Scholar] [CrossRef]
  31. Aston, E.J.; Mayor, P.; Bowman, D.D.; Mohammed, H.O.; Liotta, J.L.; Kwok, O.; Dubey, J.P. Use of filter papers to determine seroprevalence of Toxoplasma gondii among hunted ungulates in remote Peruvian Amazon. Int. J. Parasitol. Parasites Wildl. 2014, 3, 15–19. [Google Scholar] [CrossRef]
  32. Nascimento, H.S. Los pueblos indígenas aislados de la “tierra indigena valle del yavari” y la epidemia de malaria y Hepatitis B y D. In Libro de Resúmenes: El Derecho a la Salud de los Pueblos Indígenas en Aislamiento y Contacto Inicial; Grupo Internacional de Trabajo Sobre Asuntos Indígenas (IWGIA), el Instituto de Promoción de Estudios Sociales (IPES) y la Fundación Biodiversidad: Quito, Ecuador, 2008; p. 72. [Google Scholar]
  33. Centro de Trabalho Indigenista: A Grave Situación das Hepatites B e D no Vale do Javari. 2004. Available online: www.trabalhoindigenista.org.br (accessed on 5 May 2024).
  34. Cabezas, C.; Trujillo, O.; Balbuena, J.; Terrazas, M.; Manrique-de Lara, C.; Marín, L.; Ramírez-Soto, M.C. Reducción en la infección por VHB y VHD en dos poblaciones indígenas de la Amazonia peruana después de la vacunación contra la hepatitis B. Salud Publ. Mex. 2020, 62, 237–245. [Google Scholar] [CrossRef]
  35. Menajovsky, M.F.; Espunyes, J.; Ulloa, G.; Calderon, M.; Diestra, A.; Malaga, E.; Muñoz, C.; Montero, S.; Lescano, A.G.; Santolalla, M.L.; et al. Toxoplasma gondii in a Remote Subsistence Hunting-Based Indigenous Community of the Peruvian Amazon. Trop. Med. Infect. 2024, 9, 98. [Google Scholar] [CrossRef]
  36. Morales, E.A.; Mayor, P.; Ventocilla, J.A.; Bowler, M.; Baldeviano, G.C.; Pérez-Velez, E.S.; Lescano, A.G.; Aysanoa, E.; Pérez, J. Prevalence of Trypanosoma cruzi and other trypanosomatids in frequently-hunted wild mammals from the Peruvian Amazon. Am. J. Trop. Med. Hyg. 2017, 97, 1482. [Google Scholar] [CrossRef] [PubMed]
  37. He, W.Q.; Chen, X.J.; Wen, Y.Q.; Li, Y.Z.; He, H.; Chen, Q. Detection of hepatitis B virus-like nucleotide sequences in liver samples from murine rodents and Asian house shrews. Vector Borne Zoonotic Dis. 2019, 19, 781–783. [Google Scholar] [CrossRef]
  38. Cuiabio: What Is Hepatitis B Virus? Available online: https://www.cusabio.com/c-20128.html#a05 (accessed on 2 August 2024).
  39. Li, J.; Ulloa, G.M.; Mayor, P.; Santolalla Robles, M.L.; Greenwood, A.D. Nucleic acid degradation after long-term dried blood spot storage. Mol. Ecol. Resour. 2024, 24, e13979. [Google Scholar] [CrossRef]
  40. Douglas, K.O.; Punu, G.; Van Vliet, N. Prioritization of zoonoses of wildlife origin for multisectoral one health collaboration in Guyana, 2022. One Health 2024, 18, 100730. [Google Scholar] [CrossRef]
  41. van Vliet, N.; Muhindo, J.; Nyumu, J.; Enns, C.; Massé, F.; Bersaglio, B.; Cerutti, P.; Nasi, R. Understanding factors that shape exposure to zoonotic and food-borne diseases across wild meat trade chains. Hum. Ecol. 2022, 50, 983–995. [Google Scholar] [CrossRef]
  42. Burnham, K.P.; Anderson, D.R. Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach, 2nd ed.; Springer: New York, NY, USA, 2002. [Google Scholar]
  43. R Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2023; Available online: https://www.R-project.org (accessed on 15 February 2024).
  44. Russell, N.K.; Nazar, K.; Del Pino, S.; Alonso Gonzalez, M.; Diaz Bermudez, X.P.; Ravasi, G. HIV, syphilis, and viral hepatitis among Latin American indigenous peoples and Afro-descendants: A systematic review. Rev. Panam. Salud Pública 2019, 43, e17. [Google Scholar] [CrossRef]
  45. Monsalve-Castillo, F.; Echevarría, J.M.; Atencio, R.; Suárez, A.; Estévez, J.; Costa-León, L.; Montiel, P.; Molero, T.; Zambrano, M. Alta prevalencia de la infección por el virus de hepatitis B en la comunidad indígena Japreira, Estado Zulia, Venezuela. Cad. Saúde Públ. 2008, 24, 1183–1186. [Google Scholar] [CrossRef]
  46. Roman, S.; Tanaka, Y.; Khan, A.; Kurbanov, F.; Kato, H.; Mizokami, M.; Panduro, A. Occult hepatitis B in the genotype H-infected Nahuas and Huichol native Mexican population. J. Med. Virol. 2010, 82, 1527–1536. [Google Scholar] [CrossRef]
  47. Craig, P.G.; Bryan, J.P.; Miller, R.E.; Reyes, L.; Hakre, S.; Jaramillo, R.; Krieg, R.E. The prevalence of hepatitis A, B and C infection among different ethnic groups in Belize. Am. J. Trop. Med. Hyg. 1993, 49, 430–434. [Google Scholar] [CrossRef] [PubMed]
  48. Vásquez, S.; Cabezas, C.; García, B.; Torres, R.; Larrabure, G.; Suarez, M.; Lucen, A.; Pernaz, G.; Gonzales, L.; Miranda, G.; et al. Prevalencia de portadores de HBsAg y anti-HBs en gestantes residentes en áreas de diferente endemicidad de HVB en departamentos del Centro-Sur del Perú. Rev. Gastroenterol. Peru. 1999, 19, 110–115. [Google Scholar]
  49. Cabezas, C.; Gotuzzo, E.; Escamilla, J.; Phillips, I. Prevalencia de marcadores serológicos de hepatitis viral A, B y Delta en escolares aparentemente sanos de Huanta (Perú). Rev. Gastroenterol. Peru 1999, 14, 123–134. [Google Scholar]
  50. Echevarría, J.M.; González, J.E.; Lewis-Ximenez, L.L.; Dos Santos, D.L.; Munné, M.S.; Pinto, M.A.; Pujol, F.; Rodríguez-Lay, L. Hepatitis E virus infection in Latin America: A review. J. Med. Virol. 2013, 85, 1037–1045. [Google Scholar] [CrossRef]
  51. Gonçalves de Campos, C.; Silveira, S.; Schenkel, D.M.; Carvalho, H.; Teixeira, E.A.; de Almeida Souza, M.; Dutra, V.; Nakazato, L.; Canal, C.W.; Pescador, C.A. Detection of hepatitis E virus genotype 3 in pigs from subsistence farms in the state of Mato Grosso, Brazil. Comp. Immunol. Microbiol. Infect. Dis. 2018, 58, 11–16. [Google Scholar] [CrossRef]
  52. Ferreiro, I.; Herrera, M.L.; González, I.; Cancela, F.; Leizagoyen, C.; Loureiro, M.; Arellano, H.; Echaides, C.; Bon, B.; Castro, G.; et al. Hepatitis E Virus (HEV) infection in captive white-collared peccaries (Pecari tajacu) from Uruguay. Transbound. Emerg. Dis. 2021, 68, 1040–1045. [Google Scholar] [CrossRef]
  53. Cangin, C.; Focht, B.; Harris, R.; Strunk, J.A. Hepatitis E seroprevalence in the United States: Results for immunoglobulins IGG and IGM. J. Med. Virol. 2019, 91, 124–131. [Google Scholar] [CrossRef]
  54. Wilhelm, B.; Waddell, L.; Greig, J.; Young, I. Systematic review and meta-analysis of the seroprevalence of hepatitis E virus in the general population across non-endemic countries. PLoS ONE 2019, 14, e0216826. [Google Scholar] [CrossRef]
  55. Ahmad, T.; Waheed, Y.; Tahir, S.; Safi, S.Z.; Fatima, K.; Afzal, M.S.; Farooqi, Z.; Qadri, I. Frequency of HEV contamination in sewerage waters in Pakistan. J. Infect. Dev. Ctries. 2010, 4, 842–845. [Google Scholar] [CrossRef]
  56. Takuissu, G.R.; Kenmoe, S.; Ndip, L.; Ebogo-Belobo, J.T.; Kengne-Ndé, C.; Mbaga, D.S.; Bowo-Ngandji, A.; Oyono, M.G.; Kenfack-Momo, R.; Tchatchouang, S.; et al. Hepatitis E Virus in Water Environments: A Systematic Review and Meta-analysis. Food Environ. Virol. 2022, 14, 223–235. [Google Scholar] [CrossRef] [PubMed]
  57. Baez, P.A.; Lopez, M.C.; Duque-Jaramillo, A.; Pelaez, D.; Molina, F.; Navas, M.C. First evidence of the Hepatitis E virus in environmental waters in Colombia. PLoS ONE 2017, 12, e0177525. [Google Scholar] [CrossRef] [PubMed]
  58. Manock, S.R.; Kelley, P.M.; Hyams, K.C.; Douce, R.; Smalligan, R.D.; Watts, D.M.; Sharp, T.W.; Casey, J.L.; Gerin, J.L.; Engle, R.; et al. An outbreak of fulminant hepatitis delta in the Waorani, an indigenous people of the Amazon basin of Ecuador. Am. J. Trop. Med. Hyg. 2000, 63, 209–213. [Google Scholar] [CrossRef]
  59. Castro-Arroyave, D.M.; Martínez-Gallego, J.A.; Montoya-Guzmán, M.; Silva, G.; Rojas Arbeláez, C.A. Hepatitis B en indígenas de América Latina: Una revisión de la literatura. Rev. Panam. Salud Pública 2023, 46, e22. [Google Scholar] [CrossRef]
  60. Uhart, M.; Pérez, A.; Rostal, M.; Robles, E.A.; Mendoza, A.P.; Nava, A.; de Paula, C.D.; Miranda, F.; Iñiguez, V.; Zambrana, C.; et al. A ‘One Health’ approach to predict emerging zoonoses in the Amazon. In Saúde Silvestre e Humana: Experiências e Perspectivas; FIOCRUZ: Rio de Janeiro, Brazil, 2013; pp. 65–73. [Google Scholar]
  61. Tumelty, L.; Fa, J.E.; Coad, L.; Friant, S.; Mbane, J.; Kamogne, C.T.; Tata, C.Y.; Ickowitz, A. A systematic mapping review of links between handling wild meat and zoonotic diseases. One Health 2023, 17, 100637. [Google Scholar] [CrossRef]
Figure 1. Location (red square) of the Nueva Esperanza community in the Yavari-Mirin River basin, a remote area on the border between Peru and Brazil, approximately 150 km far from Iquitos, the closest urban center. There is no accessibility to the study area through roads, only by river.
Figure 1. Location (red square) of the Nueva Esperanza community in the Yavari-Mirin River basin, a remote area on the border between Peru and Brazil, approximately 150 km far from Iquitos, the closest urban center. There is no accessibility to the study area through roads, only by river.
Microorganisms 12 01868 g001
Table 1. Seroprevalence of HBcAbs among wild mammals hunted in Nueva Esperanza community (Peruvian Amazon) between 2008 and 2020.
Table 1. Seroprevalence of HBcAbs among wild mammals hunted in Nueva Esperanza community (Peruvian Amazon) between 2008 and 2020.
Order, FamilySpeciesTestedPositive (%)95% CI
O. Primates 660 (0.0%)0.0–5.5%
AtelidaeAlouatta seniculus10 (0.0%)0.0–79.4%
Ateles chamek60 (0.0%)0.0–39.0%
Lagothrix l. poeppigii250 (0.0%)0.0–13.3%
PitheciidaeCacajao clavus50 (0.0%)0.0–43.5%
Plecturocebus cupreus10 (0.0%)0.0–79.4%
Pithecia monachus60 (0.0%)0.0–39.0%
CallitrichidaeSaimiri macrodon20 (0.0%)0.0–65.8%
CebidaeCebus albiforns50 (0.0%)0.0–43.5%
Sapajus macrocephalus150 (0.0%)0.0–20.4%
O. Rodentia 1221 (0.8%)0.1–0.5%
CuniculidaeCuniculus paca1221 (0.8%)0.1–0.5%
O. Cetartiodactyla 2084 (1.92%)0.75–4.8%
CervidaeMazama americana743 (4.1%)1.4–11.3%
Mazama nemorivaga90 (0.0%)0.0–29.9%
TayassuidaePecari tajacu630 (0.0%)0.0–5.8%
Tayassu pecari621 (1.6%)0.3–8.6%
O. Perissodactyla 350 (0.0%)0.0–9.9%
TapiridaeTapirus terrestris350 (0.0%)0.0–9.9%
Total 4315 (1.16%)0.5–2.7%
Table 2. Candidate models considered in the study for HBV serology.
Table 2. Candidate models considered in the study for HBV serology.
Candidate ModelskAICDeltaw
Age254.530.000.43
Sex255.911.380.22
Sex + Age355.741.210.24
Sex * Age457.492.960.10
Table 3. Candidate models considered in the study for HEV serology.
Table 3. Candidate models considered in the study for HEV serology.
Candidate ModelskAICDeltaw
Age277.170.000.50
Sex281.484.310.06
Sex + Age377.990.820.33
Sex * Age480.082.910.12
Table 4. Answers to the semi-structured survey conducted to 84 heads of families from the Nueva Esperanza community in the Peruvian Amazon. The determination of risk factors is based on the literature: HBV [4,10,13,14,15] and HEV [6,40,41].
Table 4. Answers to the semi-structured survey conducted to 84 heads of families from the Nueva Esperanza community in the Peruvian Amazon. The determination of risk factors is based on the literature: HBV [4,10,13,14,15] and HEV [6,40,41].
ActivityFrequencyHBV Risk [4,9,12,13,14]HEV Risk [6,39,40]
Consumption of wild meat100%, 84/84NoYes
Consumption of viscera from wild animals55.89%, 19/34NoYes
Consumption of animals found dead in the forest15%, 6/40NoYes
Use of safety measures when handling hunted animals0%, 0/17Yes Yes
Inspection of lesions in hunted animals41.17%, 7/17NoYes
Consumption of meat with lesions82.5%, 33/40NoYes
Injuries while handling hunted animals18.75%, 3/16Yes Yes
Preparation of meat at low temperatures47.72%, 21/44NoYes
Source of drinking water supply NoYes
-
Public water system
0%, 0/47
-
River
57.4%, 27/47
-
Rain
87.2%, 41/47
Drinking water treatment NoYes
-
No treatment (sedimentation)
76.1%, 35/46
-
Treatment
28.3%, 13/46
Source of water used for cooking NoYes
-
Rivers
82.4%, 28/34
-
Rainwater
52.9%, 18/34
Wastewater disposal after cooking NoYes
-
Household yard
26/34, 76.5%
-
River
9/34, 26.5%
-
Rustic drainage systems
3/34, 8.8%
-
Forest
1/34, 2.9%
Use of animal products as medicine19.35%, 12/62YesYes
Consumption of non-potable water100%, 84/84NoYes
Presence of domestic animals at home91.3%, 42/46YesNo
-
Cats
19%, 8/42
-
Dogs
26.2%, 11/42
-
Chicken
100%, 42/42
Presence of wild animals at home25%, 19/76YesYes
-
Birds (Brotogeris versicolurus)
73.7%, 14/19
-
Monkeys
5.3%, 1/19
-
Peccaries (Pecari tajacu)
15.8%, 3/19
-
Others
5.3%, 1/19
Presence of mice and rats at home100%, 84/84YesYes
Experienced bites from mice and rats16.7%, 14/84YesNo
Presence of bats at home98.8%, 83/84YesNo
Experienced bites from bats26.2%, 22/84Yes No
Has tattoos26.15%, 17/65YesNo
Has had surgeries or transfusions27.41%, 17/62YesNo
Use of condoms34%, 27/73YesNo
Due to the low individual correspondence between serological results and behavioral factors, no association was made between risk factors and HEV and HBV serology.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Menajovsky, M.F.; Espunyes, J.; Ulloa, G.; Montero, S.; Lescano, A.G.; Santolalla, M.L.; Cabezón, O.; Mayor, P. A Survey of Hepatitis B Virus and Hepatitis E Virus at the Human–Wildlife Interface in the Peruvian Amazon. Microorganisms 2024, 12, 1868. https://doi.org/10.3390/microorganisms12091868

AMA Style

Menajovsky MF, Espunyes J, Ulloa G, Montero S, Lescano AG, Santolalla ML, Cabezón O, Mayor P. A Survey of Hepatitis B Virus and Hepatitis E Virus at the Human–Wildlife Interface in the Peruvian Amazon. Microorganisms. 2024; 12(9):1868. https://doi.org/10.3390/microorganisms12091868

Chicago/Turabian Style

Menajovsky, María Fernanda, Johan Espunyes, Gabriela Ulloa, Stephanie Montero, Andres G. Lescano, Meddly L. Santolalla, Oscar Cabezón, and Pedro Mayor. 2024. "A Survey of Hepatitis B Virus and Hepatitis E Virus at the Human–Wildlife Interface in the Peruvian Amazon" Microorganisms 12, no. 9: 1868. https://doi.org/10.3390/microorganisms12091868

APA Style

Menajovsky, M. F., Espunyes, J., Ulloa, G., Montero, S., Lescano, A. G., Santolalla, M. L., Cabezón, O., & Mayor, P. (2024). A Survey of Hepatitis B Virus and Hepatitis E Virus at the Human–Wildlife Interface in the Peruvian Amazon. Microorganisms, 12(9), 1868. https://doi.org/10.3390/microorganisms12091868

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop